A synthetic DNA toolkit from the University of Portsmouth reaches sequences no existing method can bind.

Published in Nature Communications, it enables gene-targeting therapies, diagnostics, and DNA nanotechnology.

The researchers identify near-term laboratory applications; no clinical trials are scheduled.

Sources: Phys.org